Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 24.04.2026 FTEG.LN IE0009F7UB30 125,002.00 EUR 2,604,153.65 20.833  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 24.04.2026 GINC LN IE00BD842Y21 899,606.00 USD 56,844,946.56 63.189  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 24.04.2026 FGBL.LN IE00BYTH6121 1,020,847.00 USD 96,891,136.44 94.912  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 24.04.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,457,029.08 29.289  ...

WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite (NYSE: GVA) today announced that it has completed the acquisition of Kenny Seng Construction, strengthening Granite’s vertically-integrated construction and construction materials platform in Utah. Acquisition Highlights Expands Granite’s vertically-integrated home market in Utah, enhancing its construction and materials presence in a high-growth region. Adds end-to-end construction capabilities, including earthwork and site preparation, concrete wo...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 24.04.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,758,538.26 41.887  ...

MENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Announces Strategic $75 Million Investment in Wiliot to Scale Physical AI...

MUMBAI, Indien & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (zusammen mit seinen Tochtergesellschaften und/oder verbundenen Unternehmen „Sun Pharma“) und Organon & Co. (NYSE: OGN) („Organon“) gaben heute bekannt, dass sie eine endgültige Vereinbarung geschlossen haben, wonach Sun Pharma alle ausstehenden Aktien von Organon für 14,00 US-Dollar pro Aktie im Rahmen einer reinen Bartransaktion mit...

MUMBAI, India e JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (insieme alle sue aziende controllate e/o associate, “Sun Pharma”) e Organon & Co. (NYSE: OGN) (“Organon”) oggi ha annunciato di aver stretto un accordo definitivo che prevede l'acquisto da parte di Sun Pharma di tutte le azioni rimaste di Organon al costo di 14,00 dollari l'una in una transazione in contanti basata su una valutazione a...

MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (samen met zijn dochterondernemingen en/of geassocieerde ondernemingen, “Sun Pharma”) en Organon & Co. (NYSE: OGN) (“Organon”) hebben vandaag bekendgemaakt dat zij een definitieve overeenkomst hebben gesloten, waarbij Sun Pharma alle uitstaande aandelen van Organon zal verwerven voor US$ 14,00 dollar per aandeel. De transactie vindt vol...